Amazon.com stock may be dragging in 2025, but JPMorgan is doubling down on what it calls the company's "best idea": Prime.

enGene Holdings shares were up 7% to $3.25 after the company said that the Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation to detalimogene voraplasmid.

The CGuard Prime carotid stent. [Image from InspireMD] InspireMD announced that the FDA granted premarket approval (PMA) for its CGuard Prime carotid stent system. The CGuard embo ...

InspireMD shares soared after the company said federal regulators have granted premarket application approval for its CGuard Prime Carotid Stent System. The stock was up 50% at $3.72 in after-market ...

Explore Prime Medicine stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PRME.

Prime Medicine , Inc. (NASDAQ: PRME), a biotechnology company specializing in Prime Editing technology, has recently undergone significant strategic shifts in its pursuit of groundbreaking gene ...

On Tuesday, Citi analysts downgraded Prime Medicine (NASDAQ: PRME) stock from Buy to Neutral and significantly reduced the price target to $1.50 from the previous $10.00.Currently trading at $1.29 ...

Prime Medicine (NYSE:PRME – Get Free Report) had its price target decreased by stock analysts at Chardan Capital from $16.00 to $12.00 in a report released on Monday,Benzinga reports.The firm ...

Prime Medicine, Inc. (NYSE:PRME – Free Report) – Analysts at Wedbush issued their FY2029 earnings per share (EPS) estimates for Prime Medicine in a research report issued on Tuesday, March 18th.

Why Prime Medicine Stock Was Climbing Higher This Week. Story by Eric Volkman • 2mo. N ews of a fresh investigational program was putting some zip into the shares of gene-editing company Prime ...

Why Prime Medicine Stock Is Soaring Today. Why Prime Medicine Stock Soared Nearly 12% Higher on Monday. 2 Growth Stocks That Could Make You Richer. 2 Magnificent Growth Stocks With Room to Run.